TriMas earnings and buyback update

TriMas (TRS) has drawn investor attention after releasing its second quarter and year to date 2026 results, alongside an update on its long running share repurchase program.

The company reported second quarter sales of US$174.58 million compared with US$171.75 million a year earlier, while net income for the quarter was US$13.37 million compared with US$16.72 million in the prior year period.

For the six months to June 30, 2026, TriMas reported sales of US$342.86 million versus US$324.21 million a year before, and net income of US$814.2 million versus US$29.14 million for the same period in 2025.

During the quarter, TriMas repurchased 509,264 shares for US$18.9 million. Since the start of the program announced in 2015, the company has bought back 11,687,751 shares for a total of US$359.12 million.

TriMas shares trade at US$40.24, with a year to date share price return of 10.88% and a 1 year total shareholder return of 13.74%. This sits alongside a 55.40% 3 year total shareholder return, which indicates that momentum has been building over the longer term despite some shorter term softness.

If TriMas's recent earnings and buyback activity have you thinking about where else capital could work, this is a good moment to scan 19 top founder-led companies

TriMas now trades at US$40.24, while analyst estimates cluster closer to US$45 and internal fair value work points slightly below the current price. How should you weigh that spread before the detailed valuation work that follows?

Most Popular Narrative: 10.6% Undervalued

TriMas last closed at $40.24, while the most followed narrative sets fair value at $45 using a 7.1% discount rate and detailed long term assumptions.

Increased investment in automation, advanced IT platforms, and operational best practices is expected to unlock cost efficiencies and productivity gains across all business segments, contributing to sustainable improvements in EBITDA margin and overall profitability. Robust global trends, such as rising e commerce activity and growing demand for health, hygiene, and safety packaging, are providing durable tailwinds for TriMas' packaging and dispensing businesses, underpinning long term revenue growth and supporting higher future earnings.

Want to see what sits behind that margin story? The narrative leans on steadier revenue growth, higher net margins, and a future earnings multiple that has to do a lot of work.

Result: Fair Value of $45 (UNDERVALUED)

However, TriMas still faces real pressure from execution risks around integrating acquisitions and from regulatory shifts that could weigh on parts of its packaging portfolio.

Another view on TriMas valuation

The narrative around TriMas leans on a fair value of $45, which implies the stock is 10.6% undervalued. Using a simple P/E cross-check, the picture is less clear. TriMas trades at 17.3x earnings, above the Global Packaging industry at 16x and above its own fair ratio of 15.9x.

That places TriMas at a premium to the broader industry and slightly above where the fair ratio suggests the market could settle. This introduces more valuation risk than the narrative headline implies. The question for you is whether the margin and buyback story fully earns that premium.

Next Steps

The mix of positives and concerns around TriMas will mean different things for different investors, so this is a good moment to move quickly and test the data against your own expectations. To see that balance set out in one place, check the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond TriMas?

If TriMas has sharpened your focus on where capital works hardest, do not stop here. The next strong idea often comes from comparing several high quality setups.

• Spot potential value opportunities early by checking out 52 high quality undervalued stocks that combine solid fundamentals with prices that may not fully reflect their current profiles.
• Strengthen your income stream by reviewing 8 dividend fortresses that focus on higher yields with an emphasis on durability.
• Prioritise resilience by scanning 83 resilient stocks with low risk scores that score well on balance sheet strength and overall risk checks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.